MoviPrep and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with MoviPrep (polyethylene glycol 3350 with electrolytes).
Moderate food/lifestyle interactions
Moderate:
Polyethylene Glycol 3350 With Electrolytes Food/Lifestyle
Moderate Food Interaction
Mixing polyethylene glycol 3350 with electrolytes and starch-based food thickeners can reduce the thickening effect, which could increase the chance of the liquid going down the wrong way (aspiration), especially if you have trouble swallowing.
Also, taking oral medications within one hour of starting polyethylene glycol 3350 with electrolytes may speed up movement through your digestive system, potentially reducing the absorption and effectiveness of those medications.
Try to avoid taking other oral medications during and within one hour after starting polyethylene glycol 3350 with electrolytes.
It's important to inform your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor
MoviPrep drug interactions
There are 421 drug interactions with MoviPrep (polyethylene glycol 3350 with electrolytes).
MoviPrep disease interactions
There are 7 disease interactions with MoviPrep (polyethylene glycol 3350 with electrolytes) which include:
- inflammatory bowel disease
- intestinal obstruction disorders
- GI obstruction/perforation
- arrhythmias
- impaired gag reflex
- renal disease
- seizures
Report options
More about MoviPrep (polyethylene glycol 3350 with electrolytes)
- MoviPrep consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (407)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: laxatives
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.